News | February 23, 2012

Research Shows Majority of Americans Unaware of Severity of Heart Rhythm Disorders

February 23, 2012 – According to a new survey issued by the Heart Rhythm Society (HRS), the majority of Americans are unaware of two serious and potentially life-threatening heart rhythm disorders, atrial fibrillation (AF) and sudden cardiac arrest (SCA). Only one in three Americans have ever heard of AF or recognize the number of lives claimed each year from SCA. Throughout Heart Health Month in February, HRS spotlights the need for public education on heart rhythm disorders affecting millions of people and the specialists best suited to treat them – electrophysiologists.

More than 250,000 deaths occur each year as a result of SCA, more than breast cancer, lung cancer or AIDs. According to the recent survey, more than 65 percent of Americans not only underestimate the seriousness of SCA, but also believe SCA is a type of heart attack. While this current data does show a 5 percent increase since HRS’ 2008 survey, the lack of awareness remains high and further education is needed. Additionally, more than 2 million people in the United States live with AF, yet survey results showed only 50 percent know AF is a type of heart rhythm disorder.

“The Heart Rhythm Society is committed to helping educate the public about heart health and creating the best possible environment to improve long-term patient care,” said Bruce L. Wilkoff, MD, FHRS, CCDS, president of Heart Rhythm Society. “We want people to become more aware of the life-threatening heart rhythm conditions affecting millions of Americans every day, those that go beyond heart attacks or other well-known types of heart disease. Heart Health Month is a great time to spread the word.”

HRS developed two consumer awareness initiatives to focus on risk assessment, prevention and treatment of SCA and AF. The “Apples and Oranges” campaign explains the differences between SCA and a heart attack, while the “A-Fib Feels Like” campaign brings to light the warning signs of AF and the link between AF and stroke. Altogether, these campaigns provide detailed information to help people become more informed about common heart health issues and the field of electrophysiology.

For more information: www.HRSonline.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init